HOME >> BIOLOGY >> NEWS
Epilepsy drug poses high risk for fetal death and birth defects

St. Paul, Minn. -- The epilepsy drug valproate poses a higher risk for fetal death and birth defects than other commonly used epilepsy drugs, according to a study published in the August 8, 2006, issue of Neurology, the scientific journal of the American Academy of Neurology.

Of the four epilepsy drugs tested in the study, valproate posed the highest risk to the fetus with over 20 percent of the pregnancies exposed to valproate resulting in death or birth defects such as skull and limb deformities and brain, heart and lung problems.

The rate was lower for the drugs phenytoin, carbamazepine and lamotrigine. The study's findings are consistent with several other recent studies.

"The evidence is compelling that valproate poses a higher risk of birth defects than other commonly used epilepsy drugs," said study author Kimford Meador, MD, of the University of Florida in Gainesville, Florida and a fellow at the American Academy of Neurology. "Unfortunately, many doctors and pregnant women aren't aware of the risks."

The study examined 333 pairs of mother and child in the United States and the United Kingdom.

Meador is recommending doctors talk with their patients about the risks associated with valproate when choosing an epilepsy drug for women of child-bearing age. Patients already taking valproate should also be advised of the risk.

"Although valproate will continue to be an important treatment option in women who aren't able to use other epilepsy drugs, we're advising valproate not be used as the drug of first choice for women of child bearing potential, and when used, its dosage should be limited if possible," said Meador.


'"/>

Contact: Angela Babb
ababb@aan.com
651-695-2789
American Academy of Neurology
7-Aug-2006


Page: 1

Related biology news :

1. Epilepsy drug eases symptoms of inherited disorder that weakens muscles
2. Epilepsy by the numbers
3. Epilepsy Foundation announces free forum
4. Epilepsy and depression - A two-way street?
5. Cat hair at home poses an allergy risk, particularly for young children
6. Replacement warhead program poses challenges for weapons complex
7. Carnegie Mellon researcher proposes development of artificial cells to fight disease
8. Malaria poses additional risks for first-time mothers
9. One-two particle punch poses greater risk for astronauts
10. Mouse study reveals human X-SCID gene therapy poses substantial cancer risk
11. SNM opposes new payment caps on imaging services detailed in Federal Deficit Reduction Act

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:6/11/2019)... ... 12, 2019 , ... With a rapidly growing customer base ... Geneious Biologics platform as a premium hub for bioinformatics and computer programming capabilities. ... Geneious team has done an excellent job accommodating our specific data, resulting in ...
(Date:6/4/2019)... ... June 04, 2019 , ... In’Tech Medical ... today announced Q1-19 revenues of $31M, up 12% from Q1-18. The growth is ... strategic investments & operational excellence initiatives worldwide. , Laurent Pruvost , President ...
(Date:6/3/2019)... ... ... Stay on top of current hot topics through free webinars presented by leading experts ... so be sure to register today to save your place! Participate in the discussion ... upcoming webinars: , CLINICAL TRIALS , June 10 – A Novel Approach to Applying ...
Breaking Biology News(10 mins):
(Date:5/31/2019)... BEACH, Calif. (PRWEB) , ... May 30, 2019 ... ... future of neurotoxins, is pleased to announce the strategic acquisition of Metabiologics, Inc., ... research. The acquisition provides Object exclusive ownership and commercialization rights to a full ...
(Date:5/15/2019)... ... May 16, 2019 , ... Emulsifiers are the magic ... beverage products rely on these ingredients to create stable quality food that can ... paradigm shift triggers food formulators to seek out alternatives for starches, gums and ...
(Date:5/4/2019)... ... May 03, 2019 , ... More than three thousand ... Association, the scientist and ufologist Urandir Fernandes de Oliveira, last Thursday (25), during ... results of some research carried out by the association, in partnership with scientists ...
(Date:5/2/2019)... ... May 02, 2019 , ... Researchers from ... results documenting discrepancies between U.S. insurer policies for genetic testing and the 2019 ... hereditary breast and ovarian cancer (HBOC). , Jill S. Dolinsky, director ...
Breaking Biology Technology:
Cached News: